Insider · CIK 0001444319
Jason Raleigh Nunn
Files at RGLS (Regulus Therapeutics Inc.), ADXN (Addex Therapeutics Ltd.), ZBIO (Zenas BioPharma, Inc.). First filing Oct 14, 2025, latest Oct 14, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ZBIO: Zenas BioPharma, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 58Moderate | Zenas BioPharma, Inc. | $1.2M 63,158 shares | +6% | +332% from low0% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | ADXN Addex Therapeutics Ltd. | DDisposition to issuer Common Stock | -219,561 | $0.00 | $0 | 0 | 38 d ago |
| Sep 2, 2026 | ADXN Addex Therapeutics Ltd. | AGrant or award Common Stock | +219,561 | $0.00 | $0 | 219,561 | 38 d ago |
| Sep 2, 2026 | ADXN Addex Therapeutics Ltd. | DDisposition to issuer Stock-option (Right to Buy)derivative | -50,000 | $0.00 | $0 | 0 | 38 d ago |
| Sep 2, 2026 | ADXN Addex Therapeutics Ltd. | AGrant or award Stock-option (Right to Buy)derivative | +50,000 | $0.00 | $0 | 50,000 | 38 d ago |
| Oct 9, 2025 | ZBIO Zenas BioPharma, Inc. | POpen-market purchase Common Stockindirect: See Note 2 | +63,158 | $19.00 | $1.2M | 1,173,395 | Oct 14, 2025 |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | DDisposition to issuer Common Stock | -62,500 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | DDisposition to issuer Stock Optionderivative | -4,650 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | DDisposition to issuer Stock Optionderivative | -2,325 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | DDisposition to issuer Stock Optionderivative | -4,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | DDisposition to issuer Stock Optionderivative | -9,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | DDisposition to issuer Stock Optionderivative | -30,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | DDisposition to issuer Stock Optionderivative | -15,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | DDisposition to issuer Stock Optionderivative | -30,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | DDisposition to issuer Stock Optionderivative | -60,000 | - | - | 0 | Jun 27, 2025 |
| Jun 10, 2025 | ZBIO Zenas BioPharma, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +18,500 | $0.00 | $0 | 18,500 | Jun 12, 2025 |
| Apr 30, 2025 | RGLS Regulus Therapeutics Inc. | AGrant or award Common Stock | +62,500 | $0.00 | $0 | 62,500 | Apr 30, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.